ASTROCYTOMA, GRADE IV
Clinical trials for ASTROCYTOMA, GRADE IV explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE IV trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy takes on deadly brain cancer
Disease control OngoingThis trial tests a combination of donor immune cells (targeting a common virus) and the drug pembrolizumab (Keytruda) in 58 people with glioblastoma, an aggressive brain cancer. The goal is to see if this approach can shrink tumors and help patients live longer. The study has two…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: PHASE1, PHASE2 • Sponsor: Queensland Institute of Medical Research • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Cancer cell therapy trial for brain tumor withdrawn before starting
Disease control TerminatedThis study planned to test a new treatment combining CYNK-001 (natural killer cells from donated cord blood) with interleukin-2 in adults whose glioblastoma had returned and could be surgically removed. The goal was to see if this combination was safe and could extend the time be…
Matched conditions: ASTROCYTOMA, GRADE IV
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC